Regis Technologies, Inc., partners with pharmaceutical and biotechnology companies to help expedite drugs to market. We offer unrivaled expertise in synthesis and separations services to advance your active pharmaceutical ingredients (API) from initial process development and scale-up development, to final validation and commercial manufacturing. From our extensive organic expertise and collegiate collaborations, we can deliver the added value of our innovative, proprietary chromatography products, especially those with a chiral emphasis. And, we continue to offer fine organic chemicals as we have for almost 50 years.
GMP Manufacturing Services ? Regis Technologies partners with its customers to produce Active Pharmaceutical Ingredients (APIs) and intermediates. We have manufactured high value intermediates and APIs under GMP for over 14 years. This service can advance projects from initial process development, scale-up development through final validation and commercial manufacturing. RegisSEP™ SFC Separations Services, a superior separations technology that uses the environmentally friendly, is our most recent addition to our synthesis services. Chromatography Products ? Regis Technologies is a leading manufacturer of chromatography products, especially those with a chiral emphasis. We offer our proprietary Chiral Stationary Phases and HPLC columns as well as IAM Drug Discovery Columns, RAM and ISRP Direct Injection Columns, Ion Pairing Reagents and Buffers, and GC Derivatization Reagents. Our SFC separations service is an exciting addition to these capabilities. Pharmaceutical Services ? Regis Pharmaceutical Services support the filing of a Drug Master File (DMF) with veteran industry professionals who will collaborate with you throughout the DMF process. Fine Chemicals ? Regis Technologies has manufactured high purity fine organic chemicals according to controlled manufacturing procedures for over 30 years.
Located in Morton Grove, a suburb of Chicago, Regis Technologies, Inc., is a privately held company founded in 1956 and operated by the Glunz family. Regis continually updates and maintains a modern 36,000 square foot facility. Regis became a fully compliant GMP organization in 1993. By 2002, Regis expanded and improved every lab and manufacturing area. This included a new production facility with six dedicated reactor suites, individual kilo lab suites, an expanded quality control department and the installation of a cryogenic reactor. In 2006, we completed another multi-million dollar expansion with additional production labs, individual kilo lab suites and reactor suites.